Here is how Nektar performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for Nektar here ...

Nektar Therapeutics NKTR incurred a first-quarter 2025 adjusted loss of 22 cents per share, wider than the Zacks Consensus Estimate of a loss of 18 cents. In the year-ago quarter, the company had ...

Nektar Therapeutics (NKTR) reported a disappointing financial performance for Q1 2025, missing both earnings and revenue forecasts. The company posted an EPS of -$0.24 against a forecast of -$0.16 ...